Devang Kantesaria - Net Worth and Insider Trading

Devang Kantesaria Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Devang Kantesaria owns 1 companies in total, including Rocket Pharmaceuticals Inc (RCKT) .

Click here to see the complete history of Devang Kantesaria’s form 4 insider trades.

Insider Ownership Summary of Devang Kantesaria

Ticker	Comapny	Transaction Date	Type of Owner
RCKT	Rocket Pharmaceuticals Inc	2015-07-14	10 percent owner

Devang Kantesaria Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Devang Kantesaria Ownership Network

Ownership Network List of Devang Kantesaria

No Data

Ownership Network Relation of Devang Kantesaria

Devang Kantesaria Owned Company Details

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Devang Kantesaria is the 10 percent owner of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include Chief Medical Officer Mark Andrew White , See Remarks John Militello , and General Counsel Martin Wilson .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Devang Kantesaria made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 22,492 shares made by John Militello , a net sale of 48,601 shares made by Gaurav Shah , and a net sale of 582,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 19,727 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 19,727 shares. During the past 18 months, 779,172 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 779,172 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

Devang Kantesaria Mailing Address

Above is the net worth, insider trading, and ownership report for Devang Kantesaria. You might contact Devang Kantesaria via mailing address: 1400 Liberty Ridge Drive, Suite 103, Wayne Pa 19087.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.